Terms: = Uterine cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270
19 results:
1. Surgical removal of FIGO type 0 and 1 fibroids ameliorates the expression of endometrial proinflammatory transcription factors and receptivity modulators.
Dokuzeylül Güngör N; Önal M; Madenli AA; Ağar M
Fertil Steril; 2023 Mar; 119(3):504-513. PubMed ID: 36473610
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.
Ding L; Bi Z; Wu J; Zhu J; Yu Y; Yao HR; Liu YM
Arch Gynecol Obstet; 2023 Mar; 307(3):891-901. PubMed ID: 35708782
[TBL] [Abstract] [Full Text] [Related]
3. Combined expression of hoxa11 and CD10 identifies endometriosis versus normal tissue and tumors.
Bergman-Larsson J; Gustafsson S; Méar L; Huvila J; Tolf A; Olovsson M; Pontén F; Edqvist PD
Ann Diagn Pathol; 2022 Feb; 56():151870. PubMed ID: 34844098
[TBL] [Abstract] [Full Text] [Related]
4. Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
Ge F; Tie W; Zhang J; Zhu Y; Fan Y
J Clin Lab Anal; 2021 Nov; 35(11):e24015. PubMed ID: 34606634
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of hoxa11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.
Kong C; Zhu Z; Li Y; Xue P; Chen L
Clin Transl Oncol; 2021 Jul; 23(7):1334-1341. PubMed ID: 33515421
[TBL] [Abstract] [Full Text] [Related]
6. Deregulation of H19 is associated with cervical carcinoma.
Roychowdhury A; Samadder S; Das P; Mazumder DI; Chatterjee A; Addya S; Mondal R; Roy A; Roychoudhury S; Panda CK
Genomics; 2020 Jan; 112(1):961-970. PubMed ID: 31229557
[TBL] [Abstract] [Full Text] [Related]
7. Decreased expression of LIF mRNA in patients withmyoma uteri.
Kara M; Sabah Ozcan S; Aran T; Kara O; Yilmaz N
J Cell Biochem; 2019 Mar; 120(3):3423-3427. PubMed ID: 30242886
[TBL] [Abstract] [Full Text] [Related]
8. Development of the human female reproductive tract.
Cunha GR; Robboy SJ; Kurita T; Isaacson D; Shen J; Cao M; Baskin LS
Differentiation; 2018; 103():46-65. PubMed ID: 30236463
[TBL] [Abstract] [Full Text] [Related]
9. Response of xenografts of developing human female reproductive tracts to the synthetic estrogen, diethylstilbestrol.
Cunha GR; Kurita T; Cao M; Shen J; Robboy SJ; Baskin L
Differentiation; 2017; 98():35-54. PubMed ID: 29102757
[TBL] [Abstract] [Full Text] [Related]
10. Molecular mechanisms of development of the human fetal female reproductive tract.
Cunha GR; Kurita T; Cao M; Shen J; Robboy S; Baskin L
Differentiation; 2017; 97():54-72. PubMed ID: 29053991
[TBL] [Abstract] [Full Text] [Related]
11. The long noncoding RNA hoxa11 antisense induces tumor progression and stemness maintenance in cervical cancer.
Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
[TBL] [Abstract] [Full Text] [Related]
12. Expression of Endometrial Receptivity Genes Increase After Myomectomy of Intramural Leiomyomas not Distorting the Endometrial Cavity.
Unlu C; Celik O; Celik N; Otlu B
Reprod Sci; 2016 Jan; 23(1):31-41. PubMed ID: 26507873
[TBL] [Abstract] [Full Text] [Related]
13. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
Awunor O; Berger D; Kirisits C
Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
[TBL] [Abstract] [Full Text] [Related]
14. Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma.
Chen J; Fu Z; Ji C; Gu P; Xu P; Yu N; Kan Y; Wu X; Shen R; Shen Y
Biomed Pharmacother; 2015 May; 72():83-90. PubMed ID: 26054679
[TBL] [Abstract] [Full Text] [Related]
15. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
[TBL] [Abstract] [Full Text] [Related]
16. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity.
Rackow BW; Taylor HS
Fertil Steril; 2010 Apr; 93(6):2027-34. PubMed ID: 18555231
[TBL] [Abstract] [Full Text] [Related]
17. hoxa11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
Fiegl H; Windbichler G; Mueller-Holzner E; Goebel G; Lechner M; Jacobs IJ; Widschwendter M
Int J Cancer; 2008 Aug; 123(3):725-9. PubMed ID: 18478570
[TBL] [Abstract] [Full Text] [Related]
18. Frequent hoxa11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.
Whitcomb BP; Mutch DG; Herzog TJ; Rader JS; Gibb RK; Goodfellow PJ
Clin Cancer Res; 2003 Jun; 9(6):2277-87. PubMed ID: 12796396
[TBL] [Abstract] [Full Text] [Related]
19. Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure.
Li S; Ma L; Chiang T; Burow M; Newbold RR; Negishi M; Barrett JC; McLachlan JA
Mol Carcinog; 2001 Dec; 32(4):213-9. PubMed ID: 11746833
[TBL] [Abstract] [Full Text] [Related]